TRIM25 and neoplasm: While the study highlighted TRIM25 as a potential target for RIPK3-dependent necrosis-related diseases, the possible impact of regulation of this particular cell death modality by TRIM25 on the therapy resistance of tumor cells has not been addressed so far and awaits further investigations.